• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表观遗传学与系统性硬化症

Epigenetics and systemic sclerosis.

作者信息

Altorok Nezam, Kahaleh Bashar

机构信息

Division of Rheumatology, Department of Internal Medicine, University of Toledo Medical Center, 3000 Arlington Ave., Mailstop 1186, Toledo, OH, 43614, USA,

出版信息

Semin Immunopathol. 2015 Sep;37(5):453-62. doi: 10.1007/s00281-015-0504-6. Epub 2015 Jul 11.

DOI:10.1007/s00281-015-0504-6
PMID:26162437
Abstract

Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by vascular injury, activation of the immune system, and diffuse tissue fibrosis. The precise etiology of SSc is undetermined, but there is evidence suggestive of a connection between environmental factors and SSc pathogenesis. In general, harmful environmental factors are sensed by the epigenetic regulatory mechanisms that alter host gene expression leading to the emergence of disease-specific phenotype. There are three epigenetic mechanisms involved in gene regulation: DNA methylation, histone modifications, and microRNAs. Although there is evidence that SSc phenotype could be, to a some degree, determined by genetic variants, it is clear now that non-genetic factors outweigh the genetic risk in SSc. Accordingly, the environment can trigger epigenetic regulation that in turn establishes a molecular framework linking environmental exposures to genetics, leading to the disease process, possibly in a genetically predisposed host. Although we have just begun to appreciate the potential role of epigenetics in SSc, many important and promising clues have been observed. In this review, we will summarize the work that has been done in the field of epigenetic regulation in SSc, and we will discuss possible factors and mechanisms that may lead to epigenetic dysregulation in SSc.

摘要

系统性硬化症(SSc)是一种自身免疫性结缔组织疾病,其特征为血管损伤、免疫系统激活和弥漫性组织纤维化。SSc的确切病因尚未确定,但有证据表明环境因素与SSc发病机制之间存在关联。一般来说,有害环境因素由表观遗传调控机制感知,这些机制会改变宿主基因表达,导致疾病特异性表型的出现。基因调控涉及三种表观遗传机制:DNA甲基化、组蛋白修饰和微小RNA。虽然有证据表明SSc表型在一定程度上可能由基因变异决定,但现在很清楚,在SSc中,非遗传因素比遗传风险更为重要。因此,环境可触发表观遗传调控,进而建立一个将环境暴露与遗传学联系起来的分子框架,可能在具有遗传易感性的宿主中导致疾病进程。尽管我们才刚刚开始认识到表观遗传学在SSc中的潜在作用,但已经观察到许多重要且有前景的线索。在本综述中,我们将总结在SSc表观遗传调控领域所做的工作,并讨论可能导致SSc表观遗传失调的因素和机制。

相似文献

1
Epigenetics and systemic sclerosis.表观遗传学与系统性硬化症
Semin Immunopathol. 2015 Sep;37(5):453-62. doi: 10.1007/s00281-015-0504-6. Epub 2015 Jul 11.
2
Epigenetics and pathogenesis of systemic sclerosis; the ins and outs.系统性硬化症的表观遗传学与发病机制;来龙去脉
Hum Immunol. 2018 Mar;79(3):178-187. doi: 10.1016/j.humimm.2018.01.003. Epub 2018 Jan 9.
3
Genetic and epigenetic abnormalities in systemic sclerosis.系统性硬化症中的遗传和表观遗传异常。
J Dermatol. 2016 Jan;43(1):10-8. doi: 10.1111/1346-8138.13221.
4
Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.表观遗传机制:在系统性硬化症发病机制中的新作用及其治疗潜力
Int J Biochem Cell Biol. 2015 Oct;67:92-100. doi: 10.1016/j.biocel.2015.05.023. Epub 2015 Jun 1.
5
The role of genetics and epigenetics in the pathogenesis of systemic sclerosis.遗传学和表观遗传学在系统性硬化症发病机制中的作用。
Nat Rev Rheumatol. 2014 Nov;10(11):671-81. doi: 10.1038/nrrheum.2014.128. Epub 2014 Aug 19.
6
Epigenetics, the holy grail in the pathogenesis of systemic sclerosis.表观遗传学,系统性硬化症发病机制中的圣杯。
Rheumatology (Oxford). 2015 Oct;54(10):1759-70. doi: 10.1093/rheumatology/keu155. Epub 2014 Apr 16.
7
Unfolding the pathogenesis of scleroderma through genomics and epigenomics.通过基因组学和表观基因组学揭示硬皮病的发病机制。
J Autoimmun. 2017 Sep;83:73-94. doi: 10.1016/j.jaut.2017.05.004. Epub 2017 May 16.
8
New insights into the genetics and epigenetics of systemic sclerosis.系统性硬化症的遗传学和表观遗传学新见解。
Nat Rev Rheumatol. 2018 Nov;14(11):657-673. doi: 10.1038/s41584-018-0099-0.
9
Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.微小RNA在系统性硬化症发病机制中的关键作用:新进展、挑战与潜在方向
Int Immunopharmacol. 2015 Sep;28(1):626-33. doi: 10.1016/j.intimp.2015.07.042. Epub 2015 Aug 1.
10
Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.硬皮病成纤维细胞中I型胶原蛋白表达增强与FLI1基因表观遗传抑制之间的关联。
Arthritis Rheum. 2006 Jul;54(7):2271-9. doi: 10.1002/art.21948.

引用本文的文献

1
Di (2-ethylhexyl) Phthalate decrease pregnancy rate via disrupting the microbe-gut-hypothalamic-pituitary-ovarian axis in mice.邻苯二甲酸二(2-乙基己基)酯通过破坏小鼠体内微生物-肠道-下丘脑-垂体-卵巢轴降低妊娠率。
NPJ Biofilms Microbiomes. 2025 Jun 13;11(1):107. doi: 10.1038/s41522-025-00742-6.
2
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis.细胞外囊泡作为系统性硬化症中肺动脉高压的潜在生物标志物
Pharmaceuticals (Basel). 2025 Feb 14;18(2):259. doi: 10.3390/ph18020259.
3
Metallopeptidades 2 and 9 genes epigenetically modulate equine endometrial fibrosis.

本文引用的文献

1
Nongenetic inheritance and transgenerational epigenetics.非遗传和跨代表观遗传学。
Trends Mol Med. 2015 Feb;21(2):134-44. doi: 10.1016/j.molmed.2014.12.004. Epub 2014 Dec 19.
2
Hypomethylation and overexpression of ITGAL (CD11a) in CD4(+) T cells in systemic sclerosis.系统性硬化症中CD4(+) T细胞中ITGAL(CD11a)的低甲基化和过表达
Clin Epigenetics. 2014 Nov 11;6(1):25. doi: 10.1186/1868-7083-6-25. eCollection 2014.
3
Endothelial dysfunction in systemic sclerosis.系统性硬化症中的内皮功能障碍
金属肽酶2和9基因通过表观遗传调控马子宫内膜纤维化。
Front Vet Sci. 2022 Aug 12;9:970003. doi: 10.3389/fvets.2022.970003. eCollection 2022.
4
Novel Concepts in Systemic Sclerosis Pathogenesis: Role for miRNAs.系统性硬化症发病机制的新观念:微小RNA的作用
Biomedicines. 2021 Oct 14;9(10):1471. doi: 10.3390/biomedicines9101471.
5
Epigenetic down-regulation of microRNA-126 in scleroderma endothelial cells is associated with impaired responses to VEGF and defective angiogenesis.硬皮病内皮细胞中 microRNA-126 的表观遗传下调与对 VEGF 反应受损和血管生成缺陷有关。
J Cell Mol Med. 2021 Jul;25(14):7078-7088. doi: 10.1111/jcmm.16727. Epub 2021 Jun 17.
6
Modulation of microRNome by Human Cytomegalovirus and Human Herpesvirus 6 Infection in Human Dermal Fibroblasts: Possible Significance in the Induction of Fibrosis in Systemic Sclerosis.人类巨细胞病毒和人类疱疹病毒 6 感染对人真皮成纤维细胞 microRNome 的调节:在系统性硬皮病纤维化诱导中的可能意义。
Cells. 2021 Apr 29;10(5):1060. doi: 10.3390/cells10051060.
7
The Pathogenesis of Systemic Sclerosis: An Understanding Based on a Common Pathologic Cascade across Multiple Organs and Additional Organ-Specific Pathologies.系统性硬化症的发病机制:基于多器官共同病理级联反应及其他器官特异性病理改变的认识
J Clin Med. 2020 Aug 19;9(9):2687. doi: 10.3390/jcm9092687.
8
Epigenetics and systemic sclerosis: An answer to disease onset and evolution?表观遗传学与系统性硬化症:疾病发生与演变的答案?
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S147-S156. doi: 10.5152/eurjrheum.2020.19112. Epub 2020 Jul 20.
9
Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts.甲基化 CpG 结合蛋白 2 在硬皮病成纤维细胞中发挥抗纤维化作用。
Ann Rheum Dis. 2018 Aug;77(8):1208-1218. doi: 10.1136/annrheumdis-2018-213022. Epub 2018 May 14.
10
From genetics to epigenetics: new insights into keloid scarring.从遗传学到表观遗传学:瘢痕疙瘩形成的新见解
Cell Prolif. 2017 Apr;50(2). doi: 10.1111/cpr.12326. Epub 2017 Jan 5.
Curr Opin Rheumatol. 2014 Nov;26(6):615-20. doi: 10.1097/BOR.0000000000000112.
4
Advances in the profiling of DNA modifications: cytosine methylation and beyond.DNA 修饰谱分析的进展:胞嘧啶甲基化及其他。
Nat Rev Genet. 2014 Oct;15(10):647-61. doi: 10.1038/nrg3772. Epub 2014 Aug 27.
5
Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.弥漫性和局限性系统性硬化症患者皮肤成纤维细胞的全基因组DNA甲基化分析揭示了常见和亚型特异性的DNA甲基化异常。
Ann Rheum Dis. 2015 Aug;74(8):1612-20. doi: 10.1136/annrheumdis-2014-205303. Epub 2014 May 8.
6
Epigenetics, the holy grail in the pathogenesis of systemic sclerosis.表观遗传学,系统性硬化症发病机制中的圣杯。
Rheumatology (Oxford). 2015 Oct;54(10):1759-70. doi: 10.1093/rheumatology/keu155. Epub 2014 Apr 16.
7
Single-cell DNA-methylation analysis reveals epigenetic chimerism in preimplantation embryos.单细胞 DNA 甲基化分析揭示了胚胎植入前胚胎中的表观遗传嵌合体。
Science. 2013 Sep 6;341(6150):1110-2. doi: 10.1126/science.1240617.
8
Aberrant histone modification in peripheral blood B cells from patients with systemic sclerosis.系统性硬化症患者外周血 B 细胞中的组蛋白修饰异常。
Clin Immunol. 2013 Oct;149(1):46-54. doi: 10.1016/j.clim.2013.06.006. Epub 2013 Jun 20.
9
Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma.硬皮病中骨形态发生蛋白受体 II 表达的表观遗传抑制。
J Cell Mol Med. 2013 Oct;17(10):1291-9. doi: 10.1111/jcmm.12105. Epub 2013 Jul 16.
10
The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis.Wnt 拮抗剂 DKK1 和 SFRP1 可因启动子超甲基化在系统性硬皮病中下调。
Ann Rheum Dis. 2014 Jun;73(6):1232-9. doi: 10.1136/annrheumdis-2012-203194. Epub 2013 May 22.